Atlas Trials

Initial Investigation of [18F]P16-129 in Alzheimer's Disease Patients and Healthy Volunteers

Clinical trial NCT03902548 · COMPLETED

Trial details

NCT number
NCT03902548
Sponsor
Five Eleven Pharma, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2018-02-21
Primary completion
2019-11-02
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.